HBL ENGINEERING LIMITED — Stage 4 setup with EFS 48.9 and investment score 40.7.
Treat FY2025-26 as a breakout year, but do not assume linearity: management explicitly warns that sales/PBT will vary and that the flagship Kavach business can see margin volatility.
The core question is durability: can HBL diversify away from Kavach before competition and contract-mix normalise margins?
What changed in FY2025-26: the annual report shows a sharp step-up in scale and profitability (headline: revenue ~₹3,252 Cr and PAT ~₹797 Cr), plus strong operating cash generation. The same report also flags that quarterly profitability will vary (especially due to Kavach contract mix).
Future setup (company’s own framing): management describes a portfolio of nine business units, with four expected to contribute most over the next ~4 years: Kavach, industrial Ni-Cd batteries, electronic fuzes, and electric drive trains for trucks. It also frames a FY2030 scenario of >₹5,000 Cr sales as a scenario, not a prediction.
Bull case: Kavach execution leadership sustains near-term cash flows; defence approvals (electronic fuzes) convert into repeat orders; industrial batteries (especially Ni-Cd + exports) remain a steady engine; and the EV drivetrain platform reaches a commercial scale without heavy dilution.
Bear case: Kavach becomes more competitive (margin compression + slower order conversion), revenue recognition and project-cost estimation create earnings volatility, batteries face mix/price pressure (telecom shift toward lithium), and newer bets (EV drivetrain/startup investments) absorb capital without commensurate returns.
What it means for long-term investors: treat HBL as a high-variance, engineering-led portfolio. Confidence should rise only if (1) profit pool broadens beyond Kavach, (2) audited cash conversion stays strong, and (3) capital allocation remains disciplined (R&D/dividends vs non-core equity-market/startup deployments).
What it means for traders: the current technical snapshot is defensive (Supertrend SELL, price below key moving averages). That usually means: prefer defined-risk setups (pullbacks to support, breakout + retest, or trend flip confirmation) over chasing. A cleaner trend setup would typically require a sustained reclaim of SMA20/50, improving RSI, and a Supertrend flip.
Agent Adda scores from snapshot (Agent Adda cached snapshot). Useful ranking signals — not standalone buy/sell rules.
EFS 48.9 is the composite fundamental score: it indicates a reasonably strong combination of earnings quality (93.8), sales growth (95.0), financial strength (93.0), and institutional bias (65.0). The weaker sales-growth/financial-strength components are why the score is not a clean quality signal. Investment Score 40.7 is lower because it blends the fundamental stack with the current technical setup, where the technical score is 19.3. In plain English: the tape is stronger than the balance-sheet evidence, so the stock can screen well for momentum without removing execution, leverage, or valuation risk. Validate the scores against audited cash flow, debt, margins, dilution, and the next two quarters before treating them as conviction.
Business profile is grounded in the FY2025-26 annual report + NSE iXBRL/filings; treat all forward-looking statements as management claims.
HBL positions itself as a company that fills “technology gaps” via in-house R&D and niche manufacturing. It operates across industrial electronics (rail signalling/Kavach), industrial batteries (lead, Ni-Cd, lithium), and defence (batteries + electronic fuzes).
If proprietary design + execution know-how is real (and repeatable), niches can sustain pricing and margins. Kavach leadership and defence-qualification barriers are the two biggest potential moats.
Project businesses can be lumpy and accounting-judgment heavy; dependence on one profit pool (Kavach) can amplify volatility when competition rises or contract mix shifts.
Primary-source 5-year snapshot from the FY2025-26 annual report. This is a headline table; reconcile segment-mix, order execution timing, and any exceptional items with the audited notes.
| Period | Revenue | Op. Profit | OPM | PAT | EPS | Payout |
|---|---|---|---|---|---|---|
| Mar 2023 | 1,369 | 151 | 11% | 98 | 3.56 | 13% |
| Mar 2024 | 2,233 | 423 | 19% | 280 | 10.13 | 5% |
| Mar 2025 | 1,967 | 393 | 20% | 276 | 9.99 | 10% |
| Mar 2026 | 3,303 | 1,113 | 34% | 814 | 29.40 | 3% |
| TTM | 3,339 | 1,068 | 32% | 780 | 28.17 |
6 quarterly periods are available. Jun 2026 revenue was 638 Cr and PAT 109 Cr; the latest sequential change was revenue +5.6% and PAT +70.3%. Use the next filing to test whether the latest growth rate is recurring and whether operating margin and cash conversion are moving with earnings. Primary-source cross-check (NSE iXBRL Q3 FY26): Revenue from ops ₹874.04 Cr; PAT ₹217.56 Cr; segment revenue: Industrial Batteries: 346.66 Cr | Defence & Aviation Batteries: 39.07 Cr | Electronics: 473.34 Cr.
| Quarter | Revenue | Op. Profit | OPM | PAT | EPS |
|---|---|---|---|---|---|
| Mar 2025 | 476 | 79 | 17% | 45 | 1.62 |
| Jun 2025 | 602 | 192 | 32% | 143 | 5.17 |
| Sep 2025 | 1,223 | 544 | 44% | 387 | 13.97 |
| Dec 2025 | 874 | 302 | 35% | 220 | 7.96 |
| Mar 2026 | 604 | 75 | 12% | 64 | 2.30 |
| Jun 2026 | 638 | 147 | 23% | 109 | 3.94 |
3 balance-sheet/cash-flow periods are available. Latest reported borrowings are 67 Cr, CFO is 738 Cr, and FCF is 618 Cr. Read these alongside PAT, working-capital movements, capex, and financing flows: profit growth is higher quality when it converts to operating cash without repeated debt or equity funding.
| Balance sheet item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 28 | 28 | 28 |
| Reserves | 1,193 | 1,455 | 2,187 |
| Borrowings+ | 67 | 74 | 67 |
| Total Liabilities | 1,654 | 1,980 | 2,942 |
| Fixed Assets+ | 354 | 397 | 441 |
| Total Assets | 1,654 | 1,980 | 2,942 |
| Cash flow item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| CFO | 270 | 239 | 738 |
| CFI | -137 | -320 | -214 |
| CFF | -42 | -26 | -113 |
| FCF | 204 | 120 | 618 |
| Net Cash | 91 | -107 | 411 |
Evidence reviewed: 4 concall artifacts and 6 exchange/company announcements. The read-through below distinguishes reported numbers, management claims, and checks required before relying on the catalyst.
Newest exchange filings + extracted highlights (verify the source PDF/XBRL before thesis).
Annual report (company site PDF). Use this as the primary narrative source; reconcile figures with audited statements and NSE/BSE filings. 📄 View Annual Report PDF
| Turnover | ₹3,252 Cr (5-year snapshot, FY2025-26) |
| PAT | ₹797 Cr (5-year snapshot, FY2025-26) |
| Net Worth | ₹2,172 Cr (5-year snapshot, as of Mar-2026) |
| EPS | ₹29 (5-year snapshot, FY2025-26) |
| Book Value / Share | ₹78 (5-year snapshot, as of Mar-2026) |
| Dividend / Share | ₹3 (interim + final, FY2025-26; face value ₹1) |
| Exports | Exports: ₹520 Cr; Imports: ₹253 Cr (5-year snapshot, FY2025-26) |
The annual report explicitly warns that growth and margins will not be uniform quarter-to-quarter; the near-term earnings engine is Kavach, while the medium-term diversification hinges on industrial Ni-Cd batteries, electronic fuzes approvals, and commercialisation of electric drivetrain programs.
Not extracted.
Not extracted.
Sector and peer claims are shown only when a same-date comparable dataset is available.
| Lens | Read-through |
|---|---|
| Sector | Other |
| Data quality | No peer ranking asserted without comparable same-date observations. |
| Next check | Compare growth, margins, balance-sheet risk, valuation, and relative strength with the company’s listed peers. |
Peer ranking omitted: no comparable same-date peer dataset was supplied, so this report does not manufacture a self-comparison row.
EOD chart from Agent Adda cached price history (130 bars). Range: 2026-02-10 → 2026-08-17.
Technical setup from cached snapshot (if available).
| Indicator | Value | Note |
|---|---|---|
| Stage | Stage 4 | Weinstein stage |
| Signal | SELL | Snapshot |
| RSI | 43.0 | Momentum |
| ADX | 31.0 | Trend strength |
| SMA20/50/200 | 683.17 / 724.61 / 769.08 | Trend context |
| Supertrend | SELL | Trend filter |
| Ratio | Value |
|---|---|
| Market cap | INR 19,519 Cr |
| P/E | 24.3x |
| ROCE | 58.4% |
| ROE | 45.3% |
| Book value | INR 79.9 |
| High / Low | 1122.0 / 570.0 |
| Dividend yield | 0.42% |
The snapshot labels the stock Stage 4 (Stage 4 downtrend). Weinstein stage describes the position of price within a multi-month trend: Stage 1 is a base, Stage 2 an advance, Stage 3 a topping range, and Stage 4 a decline. It is a context framework, not a forecast or standalone trade signal.
Evidence check: price is not above all the 20/50/200-day averages, and the moving averages are not fully stacked bullishly (683.17 / 724.61 / 769.08). RSI is 43.0 (weak momentum); ADX is 31.0 (strong trend); Supertrend is SELL. A bullish stage with weak momentum, a broken moving-average stack, or a conflicting Supertrend reading is a lower-quality setup.
Practical conclusion: watchlist-quality setup only when earnings acceleration, leadership, volume, and a definable risk point align.
Broker/analyst evidence is shown only when dated source results are returned.
Illustrative valuation from TTM EPS and P/E multiples (not a recommendation).
| Scenario | TTM EPS | P/E | Implied value | vs current | Condition required |
|---|---|---|---|---|---|
| Bear (multiple compression) | 28.17 | 17x | 479 | -32% | Risk-off, slower growth, lower multiple. |
| Base (current multiple) | 28.17 | 24x | 685 | -3% | Steady execution; multiple holds. |
| Bull (multiple expansion) | 28.17 | 29x | 821 | +17% | Sustained growth + quality premium. |
HBLENGINE-specific risks from the annual-report narrative + project/defence-business realities; validate against the audited notes and the newest NSE filings.
| Risk | Why it matters | Severity | What to monitor |
|---|---|---|---|
| Kavach concentration + competition | Kavach is a large profit pool; contract mix and future competitive intensity can compress margins and increase volatility. | High | Order inflow, execution pace, margin trend, competitor wins, and customer feedback. |
| Revenue recognition / estimation risk | Project execution requires cost-to-complete estimates; errors can swing reported profits and create unpleasant surprises. | High | Disclosures on contract assets/liabilities, provisions, and auditor KAMs. |
| Defence approvals + order lumpiness | Electronic fuzes and defence products depend on testing/qualification and budget cycles; timing can be lumpy. | Medium | Approval milestones, tender pipeline, and repeat orders. |
| Battery mix disruption | Telecom + industrial tech shifts (e.g., toward lithium) can pressure legacy product lines and pricing. | Medium | Segment mix, realisations, exports, and capacity utilisation. |
| Capital allocation drift | Surplus cash deployment into startups/markets can create non-core risk if not disciplined. | Medium | Dividend policy adherence, disclosed investments, and ROI / write-offs. |
| Technical downtrend risk (for traders) | Stage 4 + Supertrend SELL raises whipsaw risk and reduces edge for aggressive longs. | Medium | Trend flip confirmation, SMA reclaims, volume confirmation, and defined invalidation levels. |
Source-first trail for review.